UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 5 von 78
Datensatz exportieren als...
BibTeX
Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: Cytotoxicity, metabolic flux, and glycan-display considerations
Biotechnology and bioengineering, 2012-04, Vol.109 (4), p.992-1006
Almaraz, Ruben T.
Aich, Udayanath
Khanna, Hargun S.
Tan, Elaine
Bhattacharya, Rahul
Shah, Shivam
Yarema, Kevin J.
2012
Details
Autor(en) / Beteiligte
Almaraz, Ruben T.
Aich, Udayanath
Khanna, Hargun S.
Tan, Elaine
Bhattacharya, Rahul
Shah, Shivam
Yarema, Kevin J.
Titel
Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: Cytotoxicity, metabolic flux, and glycan-display considerations
Ist Teil von
Biotechnology and bioengineering, 2012-04, Vol.109 (4), p.992-1006
Ort / Verlag
Hoboken: Wiley Subscription Services, Inc., A Wiley Company
Erscheinungsjahr
2012
Link zum Volltext
Quelle
Wiley Online Library - AutoHoldings Journals
Beschreibungen/Notizen
Metabolic oligosaccharide engineering (MOE) is a maturing technology capable of modifying cell surface sugars in living cells and animals through the biosynthetic installation of non‐natural monosaccharides into the glycocalyx. A particularly robust area of investigation involves the incorporation of azide functional groups onto the cell surface, which can then be further derivatized using “click chemistry.” While considerable effort has gone into optimizing the reagents used for the azide ligation reactions, less optimization of the monosaccharide analogs used in the preceding metabolic incorporation steps has been done. This study fills this void by reporting novel butanoylated ManNAc analogs that are used by cells with greater efficiency and less cytotoxicity than the current “gold standard,” which are peracetylated compounds such as Ac4ManNAz. In particular, tributanoylated, N‐acetyl, N‐azido, and N‐levulinoyl ManNAc analogs with the high flux 1,3,4‐O‐hydroxyl pattern of butanoylation were compared with their counterparts having the pro‐apoptotic 3,4,6‐O‐butanoylation pattern. The results reveal that the ketone‐bearing N‐levulinoyl analog 3,4,6‐O‐Bu3ManNLev is highly apoptotic, and thus is a promising anti‐cancer drug candidate. By contrast, the azide‐bearing analog 1,3,4‐O‐Bu3ManNAz effectively labeled cellular sialoglycans at concentrations ∼3‐ to 5‐fold lower (e.g., at 12.5–25 µM) than Ac4ManNAz (50–150 µM) and exhibited no indications of apoptosis even at concentrations up to 400 µM. In summary, this work extends emerging structure activity relationships that predict the effects of short chain fatty acid modified monosaccharides on mammalian cells and also provides a tangible advance in efforts to make MOE a practical technology for the medical and biotechnology communities. Biotechnol. Bioeng. 2012; 109:992–1006. © 2011 Wiley Periodicals, Inc. Per‐acetylated N‐azido‐mannosamine (Ac4ManNAz) is a widely used metabolic substrate for labeling sialic acids in living cells and animals. In this work the authors show that n‐butanoylated ManNAz can achieve higher flux through the sialic acid biosynthetic pathway and highlight structure‐activity relationships where tributanoylated analog with the “3,4,6” pattern of butyrate derivation is highly toxic while the corresponding “1,3,4” analog has negligible toxicity and thus serves as an optimal molecular tool for incorporating azide groups into cellular sialoglycans.
Sprache
Englisch
Identifikatoren
ISSN: 0006-3592
eISSN: 1097-0290
DOI: 10.1002/bit.24363
Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3288793
Format
–
Schlagworte
Acylation
,
Adenocarcinoma - pathology
,
Animals
,
Antineoplastic Agents - chemistry
,
Antineoplastic Agents - toxicity
,
apoptosis
,
Apoptosis - drug effects
,
Azides - analysis
,
Azides - chemistry
,
Breast Neoplasms - pathology
,
Butyric Acid
,
Cell Cycle - drug effects
,
Cell Line, Tumor - drug effects
,
Cell Line, Tumor - metabolism
,
cell surface labeling
,
CHO Cells - drug effects
,
CHO Cells - metabolism
,
Click Chemistry
,
Cricetinae
,
Cricetulus
,
Drug Design
,
Glycocalyx - metabolism
,
Glycoconjugates - analysis
,
glycosylation
,
Hexosamines - chemical synthesis
,
Hexosamines - chemistry
,
Hexosamines - metabolism
,
Hexosamines - toxicity
,
Humans
,
Jurkat Cells - drug effects
,
Jurkat Cells - metabolism
,
Ketones - analysis
,
ManNAc analogs
,
metabolic oligosaccharide engineering
,
Molecular Structure
,
N-Acetylneuraminic Acid - metabolism
,
Pancreatic Neoplasms - pathology
,
sialic acid biosynthesis
,
Structure-Activity Relationship
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX